Aiplexity

Active market brief

Broad relief trading remains fragile against weak short-term trends and upcoming macro catalysts. Selective confirmed post-earnings bases offer positive expected net returns; broader market softness serves as a positioning input rather than an outright equity veto.

monitoring View performance Performance history Browse history History

query_stats Key stats

Lead pick XEL Xcel Energy Inc. Top current gain among active picks - +1.7%

Strategy gain Recent 7 days +1.2% As of Nov 04, 02:06 PM EST

Selection hit rate Selected in past 7 days 50%

Active picks Inside active strategy window 4

Research output

Current picks

History arrow_forward

Latest pick DD Nov 4 9am DuPont de Nemours, Inc. Recommendation & Actionability: DuPont de Nemours, Inc. (NYSE: DD) is the authoritative immediate-buy selection for November 4, 2026, delivering an expected absolute net return of +0.5506% and an expected excess return of +1.1174% over the matched... Latest investment pick, currently -0.2%. DD Open analysis arrow_forward

Foggy mountains with green slopes and dense forest

AME -5.4% AMETEK, Inc. Selected Pick & Execution Classification: AMETEK, Inc. (NYSE: AME) is selected as an immediate-entry Momentum buy under the authoritative authored research baseline price of $250.665 (timestamped November 3, 2026 at 2:03 PM EST ), with continuous publication... Research brief Nov 3 1pm

PFE +0.9% Pfizer Inc. Recommendation and Core Thesis: Immediate buy instruction for Pfizer Inc. (PFE) at authored research entry price $30.350 under execution policy authoredstopma60confirm120hard15confirm10tp1p8v1. The selection is driven by Pfizer's fresh third-quarter 2026... Research brief Nov 3 11am

history More Historical Picks